Significance of antinuclear antibodies in patients with COVID-19
Oh-Hyun Cho
Korean J Intern Med. 2023;38(3):280-281. Published online 2023 Apr 28 DOI: https://doi.org/10.3904/kjim.2023.155
Citations to this article as recorded by 
Autoantibodies directed against interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 are not induced by SARS-CoV-2 or associated with long COVID
Adam Epstein-Shuman, Joanne H. Hunt, Patrizio Caturegli, Patrick Winguth, Reinaldo E. Fernandez, Gracie M. Rozek, Xianming Zhu, Nicholas A. DiRico, Armaan Jamal, Yu-Hsiang Hsieh, Yukari C. Manabe, Andrew D. Redd, Steven J. Reynolds, Annukka A.R. Antar, Ol
International Journal of Infectious Diseases.2025; 150: 107289. CrossRef
Autoantibodies to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 in a Ugandan cohort and their relation to SARS-CoV-2 infection
Adam Epstein-Shuman, Xianming Zhu, Joanne H. Hunt, Reinaldo E. Fernandez, Gracie M. Rozek, Andrew D. Redd, Zoe A. Gotthold, Gabriel Quiros, Ronald M. Galiwango, Godfrey Kigozi, Patrizio Caturegli, Robert Ssekubugu, Mary K. Grabowski, Larry W. Chang, Steve
Journal of Infection and Public Health.2025; 18(6): 102722. CrossRef
From infection to autoimmunity: can COVID-19 spark new auto-immune conditions?
Mourad Elghali, Mariem Mhiri, Imen Chaabene, Ines Bayar, Bilel Ben Amor, Imen Jaziri, Maha Changuel, Rihab Ben Dhia, Narjes Gouta, Jamel Saad, Rym Hadhri, Ahmed Zrig, Soumaya Boudokhane, Hela Marmouche, Mahbouba Jguirim, Nabil Sakly
Respiratory Medicine Case Reports.2025; 55: 102216. CrossRef